Compartmentalized cross-linked enzyme nano aggregates (c-CLEnAs) toward pharmaceutical transformations

Journal Article (2021)
Authors

M. Teresa De Martino (Eindhoven University of Technology)

F. Tonin (TU Delft - BT/Biocatalysis)

Victor R.L.J. Bloemendal (Radboud Universiteit Nijmegen, Eindhoven University of Technology)

Ulf Hanefeld (TU Delft - BT/Biocatalysis)

Floris P.J.T. Rutjes (Radboud Universiteit Nijmegen)

Jan C.M. Van Hest (Eindhoven University of Technology)

Research Group
BT/Biocatalysis
Copyright
© 2021 M. Teresa de Martino, F. Tonin, Victor R.L.J. Bloemendal, U. Hanefeld, Floris P.J.T. Rutjes, Jan C.M. van Hest
To reference this document use:
https://doi.org/10.1039/d1ra04332c
More Info
expand_more
Publication Year
2021
Language
English
Copyright
© 2021 M. Teresa de Martino, F. Tonin, Victor R.L.J. Bloemendal, U. Hanefeld, Floris P.J.T. Rutjes, Jan C.M. van Hest
Research Group
BT/Biocatalysis
Issue number
35
Volume number
11
Pages (from-to)
21857-21861
DOI:
https://doi.org/10.1039/d1ra04332c
Reuse Rights

Other than for strictly personal use, it is not permitted to download, forward or distribute the text or part of it, without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license such as Creative Commons.

Abstract

A new immobilization strategy using compartmentalized nanoreactors is herein reported for two biocatalytic processes: (1)N-acetylneuraminate lyase (NAL) is internalized in NAL-c-CLEnAs and used in a continuous flow aldol condensation ofN-acetyl-d-mannosamine with sodium pyruvate toN-acetylneuraminic acid; (2) two hydroxysteroid dehydrogenases (HSDH) 7α- and 7β-HSDH are incorporated inc-CLEnAs and used in a two-step cascade batch synthesis of ursodeoxycholic acid (UDCA). The versatile use ofc-CLEnA demonstrates that this immobilization methodology is a valuable addition to the toolbox of synthetic chemists.